India's Ranbaxy gets tenative US nod for zolpidem

MUMBAI, March 16 (Reuters) - India's Ranbaxy Laboratories Ltd. (RANB.BO: Quote, Profile, Research, Stock Buzz) said on Friday it had received tentative approval from the U.S. Food and Drug Administration to manufacture and market zolpidem tablets, used to treat insomnia.

((Reporting by Himangshu Watts; Reuters Messaging: himangshu.watts.reuters.com@reuters.net +91 22 6636 9030)) Keywords: RANBAXY USFDA/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBMA000549